HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.

Abstract
Although trauma-hemorrhage produces tissue hypoxia, systemic inflammatory response and organ dysfunction, the mechanisms responsible for these alterations are not clear. Using a potent selective inducible nitric oxide (NO) synthase inhibitor, N-[3-(aminomethyl) benzyl]acetamidine (1400W), and a nonselective NO synthase inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME), we investigated whether inducible NO synthase plays any role in producing hepatic injury, inflammation, and changes of protein expression following trauma-hemorrhage. To investigate this, male Sprague-Dawley rats were subjected to midline laparotomy and hemorrhagic shock (mean blood pressure 35-40 mmHg for approximately 90 min) followed by fluid resuscitation. Animals were treated with either vehicle (DMSO) or 1400W (10 mg/kg body wt ip), or L-NAME (30 mg/kg iv), 30 min before resuscitation and killed 2 h after resuscitation. Trauma-hemorrhage/resuscitation induced a marked hypotension and increase in markers of hepatic injury (i.e., plasma alpha-glutathione S-transferase, tissue myeloperoxidase activity, and nitrotyrosine formation). Hepatic expression of iNOS, hypoxia-inducible factor-1alpha, ICAM-1, IL-6, TNF-alpha, and neutrophil chemoattractant (cytokine-induced neutrophil chemoattractant-1 and macrophage inflammatory protein-2) protein levels were also markedly increased following trauma-hemorrhage/resuscitation. Administration of the iNOS inhibitor 1400W significantly attenuated hypotension and expression of these mediators of hepatic injury induced by trauma-hemorrhage/resuscitation. However, administration of L-NAME could not attenuate hepatic dysfunction and tissue injury mediated by trauma-hemorrhage, although it improved mean blood pressure as did 1400W. These results indicate that increased expression of iNOS following trauma-hemorrhage plays an important role in the induction of hepatic damage under such conditions.
AuthorsWen-Hong Kan, Jun-Te Hsu, Martin G Schwacha, Mashkoor A Choudhry, Raghavan Raju, Kirby I Bland, Irshad H Chaudry
JournalJournal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 105 Issue 4 Pg. 1076-82 (Oct 2008) ISSN: 8750-7587 [Print] United States
PMID18635878 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Amidines
  • Benzylamines
  • Chemokines
  • Cytokines
  • Enzyme Inhibitors
  • Hif1a protein, rat
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Isoenzymes
  • N-(3-(aminomethyl)benzyl)acetamidine
  • Nitrates
  • Nitrites
  • Intercellular Adhesion Molecule-1
  • 3-nitrotyrosine
  • Tyrosine
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos2 protein, rat
  • Nos3 protein, rat
  • Glutathione Transferase
  • glutathione S-transferase alpha
  • NG-Nitroarginine Methyl Ester
Topics
  • Amidines (pharmacology)
  • Animals
  • Benzylamines (pharmacology)
  • Blood Pressure (drug effects)
  • Chemokines (metabolism)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Enzyme Inhibitors (pharmacology)
  • Fluid Therapy (adverse effects)
  • Glutathione Transferase (blood)
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Isoenzymes (blood)
  • Liver (drug effects, enzymology)
  • Liver Diseases (enzymology, etiology, physiopathology, prevention & control)
  • Male
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Nitrates (metabolism)
  • Nitric Oxide Synthase Type II (antagonists & inhibitors, metabolism)
  • Nitric Oxide Synthase Type III
  • Nitrites (metabolism)
  • Peroxidase (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Resuscitation (adverse effects)
  • Shock, Hemorrhagic (enzymology, physiopathology, therapy)
  • Tyrosine (analogs & derivatives, metabolism)
  • Wounds and Injuries (enzymology, physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: